Literature DB >> 6190591

Production of interferons during experimental African trypanosomiasis.

G J Bancroft, C J Sutton, A G Morris, B A Askonas.   

Abstract

African trypanosomiasis is associated with profound changes in the function of the immune system. In this study we find that alpha/beta and gamma interferon (IFN) are released into the serum of mice infected with Trypanosoma brucei. The parasite-induced rise in serum IFNs is associated with a detectable parasitaemia, but the serum IFN peak precedes the peak parasitaemia in some cases. Unlike other protozoan interferon inducers, no parasite-dependent IFN production was observed in the pre-patent period of infection; while the most virulent clone induced very high IFN levels, no clear difference in stimulation was noted in the first waves of semi-acute and chronic T. brucei clones. However, subsequent IFN augmentation more closely reflected the host parasite load and virulence of infection. The nature of the stimulatory parasite component is as yet unknown, and the parasite surface glycoprotein had no effect on serum IFN. Injection of large quantities of lethally irradiated, but intact organisms did not stimulate IFN production; however this treatment significantly impaired antibody responses to the heterologous antigen SRBC. This suggests that the more severe effects of an actual trypanosome infection are required for induction of IFN synthesis, and that the presence of measurable serum IFN is not a prerequisite for parasite-induced suppression of host antibody responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190591      PMCID: PMC1535562     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  In vitro and in vivo antiviral action of an interferon-like substance induced by Toxoplasma gondii.

Authors:  M M Freshman; T C Merigan; J S Remington; I E Brownlee
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

2.  Induction of interferon in mice infected with Toxoplasma gondii.

Authors:  M W Rytel; T C Jones
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

3.  Department of Biological Sciences, University of Warwick, Coventry, CV47AL, England.

Authors:  G J Atkins; M D Johnston; L M Westmacott; D C Burke
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

4.  The effects of interferon and its inducers on experimental protozoan parasitic infections.

Authors:  R Herman
Journal:  Trans N Y Acad Sci       Date:  1972-02

Review 5.  Effect of virus infections on the function of the immune system.

Authors:  A L Notkins; S E Mergenhagen; R J Howard
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

6.  Immunologic-mediated protection of Trypanosoma congolense-infected mice by polyribonucleotides.

Authors:  R Herman; S Baron
Journal:  J Protozool       Date:  1971-11

7.  Exogenous interferon protects mice against Plasmodium berghei malaria.

Authors:  R I Jahiel; J Vilcek; R S Nussenzweig
Journal:  Nature       Date:  1970-09-26       Impact factor: 49.962

8.  Induction of an interferon-like inhibitor by Trypanosoma cruzi infection in mice.

Authors:  M W Rytel; P D Marsden
Journal:  Am J Trop Med Hyg       Date:  1970-11       Impact factor: 2.345

9.  Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose.

Authors:  S M Lanham; D G Godfrey
Journal:  Exp Parasitol       Date:  1970-12       Impact factor: 2.011

10.  Interferon induced by Plasmodium berghei.

Authors:  K Y Huang; W W Schultz; F B Gordon
Journal:  Science       Date:  1968-10-04       Impact factor: 47.728

View more
  10 in total

1.  A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.

Authors:  M B Sztein; F Kierszenbaum
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense.

Authors:  M Oka; Y Ito
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice.

Authors:  C A Hunter; J W Gow; P G Kennedy; F W Jennings; M Murray
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Depletion of CD8+ T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma) production in infected rats.

Authors:  M Bakhiet; T Olsson; P van der Meide; K Kristensson
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Suppression by Trypanosoma brucei of anaphylaxis-mediated ion transport in the small intestine of rats.

Authors:  S S Gould; G A Castro
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

7.  Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

Authors:  Lorna Maclean; Martin Odiit; Annette Macleod; Liam Morrison; Lindsay Sweeney; Anneli Cooper; Peter G E Kennedy; Jeremy M Sternberg
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

8.  Lipopolysaccharide hyperreactivity of animals infected with Trypanosoma lewisi or Trypanosoma musculi.

Authors:  A Ferrante; R F Carter; J Ferluga; A C Allison
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.

Authors:  F Kierszenbaum; S Muthukkumar; L A Beltz; M B Sztein
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase.

Authors:  A E Millar; J Sternberg; C McSharry; X Q Wei; F Y Liew; C M Turner
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.